Matches in Nanopublications for { ?s ?p "[Because of co-activation of these two signaling pathways, we assessed the efficacy of inhibition of EGFR/HER2 receptors and the downstream KRAS effector, mitogen-activated protein kinase/extracellular-signal regulated kinase (ERK) kinase 1 and 2 (MEK1/2), on pancreatic cancer proliferation in vitro and in a murine orthotopic xenograft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP380384.RAYxFdpSHSVOsvllP6n3U_EWI1uQIbjTsTLmtmNhgzdl4130_assertion description "[Because of co-activation of these two signaling pathways, we assessed the efficacy of inhibition of EGFR/HER2 receptors and the downstream KRAS effector, mitogen-activated protein kinase/extracellular-signal regulated kinase (ERK) kinase 1 and 2 (MEK1/2), on pancreatic cancer proliferation in vitro and in a murine orthotopic xenograft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP380384.RAYxFdpSHSVOsvllP6n3U_EWI1uQIbjTsTLmtmNhgzdl4130_provenance.
- assertion description "[Because of co-activation of these two signaling pathways, we assessed the efficacy of inhibition of EGFR/HER2 receptors and the downstream KRAS effector, mitogen-activated protein kinase/extracellular-signal regulated kinase (ERK) kinase 1 and 2 (MEK1/2), on pancreatic cancer proliferation in vitro and in a murine orthotopic xenograft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Because of co-activation of these two signaling pathways, we assessed the efficacy of inhibition of EGFR/HER2 receptors and the downstream KRAS effector, mitogen-activated protein kinase/extracellular-signal regulated kinase (ERK) kinase 1 and 2 (MEK1/2), on pancreatic cancer proliferation in vitro and in a murine orthotopic xenograft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1056026.RAYenIfYkXDd1dYRFvQifeLq8eBATiAGnCD-D8xRN9HXA130_assertion description "[Because of co-activation of these two signaling pathways, we assessed the efficacy of inhibition of EGFR/HER2 receptors and the downstream KRAS effector, mitogen-activated protein kinase/extracellular-signal regulated kinase (ERK) kinase 1 and 2 (MEK1/2), on pancreatic cancer proliferation in vitro and in a murine orthotopic xenograft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056026.RAYenIfYkXDd1dYRFvQifeLq8eBATiAGnCD-D8xRN9HXA130_provenance.
- NP1056020.RACqOFl60K8St_r6tLhWoNbztR1oOqA8eNIClsm52TLmQ130_assertion description "[Because of co-activation of these two signaling pathways, we assessed the efficacy of inhibition of EGFR/HER2 receptors and the downstream KRAS effector, mitogen-activated protein kinase/extracellular-signal regulated kinase (ERK) kinase 1 and 2 (MEK1/2), on pancreatic cancer proliferation in vitro and in a murine orthotopic xenograft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056020.RACqOFl60K8St_r6tLhWoNbztR1oOqA8eNIClsm52TLmQ130_provenance.
- NP1056022.RAAy1Cuuf-ZotDaA8wdT1OX9McTJjFcZOazBE8lJx6qxo130_assertion description "[Because of co-activation of these two signaling pathways, we assessed the efficacy of inhibition of EGFR/HER2 receptors and the downstream KRAS effector, mitogen-activated protein kinase/extracellular-signal regulated kinase (ERK) kinase 1 and 2 (MEK1/2), on pancreatic cancer proliferation in vitro and in a murine orthotopic xenograft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1056022.RAAy1Cuuf-ZotDaA8wdT1OX9McTJjFcZOazBE8lJx6qxo130_provenance.